Page last updated: 2024-10-30

mebendazole and Cancer of Pancreas

mebendazole has been researched along with Cancer of Pancreas in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Limbu, KR	2
Chhetri, RB	2
Oh, YS	2
Baek, DJ	2
Park, EY	2

Other Studies

1 other study available for mebendazole and Cancer of Pancreas

Article	Year
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022